Department of Gynecology-Obstetric and Reproduction, Gynepôle, AP-HM La Conception, Marseille, France.
Department of Gynecology-Obstetric and Reproduction, Gynepôle, AP-HM La Conception, Marseille, France; IMBE, Biogénotoxicologie, Santé Humaine & Environnement UMR 6116, Aix-Marseille Université, Marseille FR CNRS 3098, ECCOREV, Aix-en-Provence, France.
Fertil Steril. 2014 Apr;101(4):994-1000. doi: 10.1016/j.fertnstert.2014.01.009. Epub 2014 Feb 15.
To identify the prognostic factors for pregnancy after intrauterine insemination with the husband's sperm (IUI-H).
Retrospective study.
A single university medical center.
PATIENT(S): 851 couples, for 2,019 IUI-H cycles.
INTERVENTION(S): After controlled ovarian stimulation, IUI-H performed 36 hours after ovulation triggering or 24 hours after a spontaneous luteinizing hormone (LH) surge.
MAIN OUTCOME MEASURE(S): Clinical pregnancy rate per cycle (PR) and delivery rate per cycle (DR).
RESULT(S): The overall PR was 14.8% and DR 10.8%. Higher PR and DR were observed for patients presenting with ovulation disorders (particularly polycystic ovary syndrome) or with male infertility. Secondary infertility in the woman appeared to be a positive prognostic factor as did a basal follicle-stimulating hormone (FSH) level ≤ 7 IU/L and ovulation triggering over spontaneous LH rise. The other parameters influencing the results were the women's age, the number of mature follicles obtained (≥ 2), the endometrial thickness (10-11 mm), and the number of progressive motile spermatozoa inseminated (>1 million).
CONCLUSION(S): In women aged ≤ 38 years, IUI-H should be considered as an option, particularly in cases of female infertility from ovulation disorders, in cases of a normal ovarian reserve, in cases of secondary infertility, or when ≥ 1 million progressive sperm are inseminated. Bifollicular stimulation is required. In other cases, in vitro fertilization should be discussed as the first-line treatment.
确定宫腔内人工授精(IUI-H)后妊娠的预后因素。
回顾性研究。
一所大学医学中心。
851 对夫妇,共 2019 个 IUI-H 周期。
在控制性卵巢刺激后,在排卵触发后 36 小时或自然黄体生成素(LH)峰后 24 小时进行 IUI-H。
每个周期的临床妊娠率(PR)和每个周期的分娩率(DR)。
总 PR 为 14.8%,DR 为 10.8%。排卵障碍(特别是多囊卵巢综合征)或男性不育患者的 PR 和 DR 更高。女性继发性不孕似乎是一个有利的预后因素,基础卵泡刺激素(FSH)水平≤7IU/L 和排卵触发超过自然 LH 峰也如此。影响结果的其他参数包括女性年龄、获得的成熟卵泡数(≥2)、子宫内膜厚度(10-11mm)和授精的前向运动精子数(>100 万)。
在≤38 岁的女性中,应考虑将 IUI-H 作为一种选择,特别是在排卵障碍引起的女性不孕、卵巢储备正常、继发性不孕或授精≥100 万前向运动精子的情况下。需要双卵泡刺激。在其他情况下,应将体外受精作为一线治疗方法进行讨论。